| |
| |
|
| Insider
Information: |
Werner Milton H. |
| Relationship: |
President and CEO, Dir... |
| City: |
Atlanta |
| State: |
GA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
5,335,433 |
|
|
Indirect Shares
|
23,589 |
|
|
| Direct
Value |
$3,254,614 |
|
|
|
Indirect Value
|
$14,389 |
|
|
| Total
Shares |
5,359,022 |
|
|
| Total
Value |
$3,269,003 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Inhibikase Therapeutics, Inc. |
IKT |
President and CEO, Dir... |
2022-08-16 |
5,335,433 |
2021-11-17 |
23,589 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IKT |
Inhibikase Therapeutics, ... |
President and CEO |
• • • |
2022-08-16 |
4 |
B |
$0.80 |
$4,000 |
D/D |
5,000 |
5,335,433 |
3.15 |
% |
|
| IKT |
Inhibikase Therapeutics, ... |
President and CEO |
• • • |
2022-05-27 |
4 |
B |
$0.98 |
$4,880 |
D/D |
5,000 |
5,330,433 |
3.15 |
% |
|
| IKT |
Inhibikase Therapeutics, ... |
President and CEO |
• • • |
2022-05-20 |
4 |
B |
$0.60 |
$6,000 |
D/D |
10,000 |
5,325,433 |
3.15 |
% |
|
| IKT |
Inhibikase Therapeutics, ... |
President and CEO |
• • • |
2022-01-03 |
4 |
OE |
$2.02 |
$44,143 |
D/D |
21,853 |
5,315,433 |
0 |
- |
|
| IKT |
Inhibikase Therapeutics, ... |
President and CEO |
• • • |
2021-11-17 |
4 |
B |
$1.93 |
$46,558 |
I/I |
23,589 |
23,589 |
2.64 |
% |
|
| IKT |
Inhibikase Therapeutics, ... |
President and CEO |
• • • |
2021-08-17 |
4 |
OE |
$2.02 |
$44,143 |
D/D |
21,853 |
5,293,580 |
0 |
- |
|
| IKT |
Inhibikase Therapeutics, ... |
President and CEO |
• • • |
2021-05-14 |
4 |
OE |
$0.38 |
$16,609 |
D/D |
43,707 |
5,288,645 |
0 |
- |
|
| IKT |
Inhibikase Therapeutics, ... |
President and CEO |
• • • |
2021-05-14 |
4 |
D |
$4.59 |
$77,654 |
D/D |
(16,918) |
5,271,727 |
0 |
- |
|
| IKT |
Inhibikase Therapeutics, ... |
President and CEOOfficer |
• • • |
2020-12-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,244,938 |
|
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
